| __timestamp | Catalyst Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 152500000 |
| Thursday, January 1, 2015 | 11801342 | 187800000 |
| Friday, January 1, 2016 | 11369941 | 184000000 |
| Sunday, January 1, 2017 | 11375237 | 167700000 |
| Monday, January 1, 2018 | 19919204 | 218600000 |
| Tuesday, January 1, 2019 | 18842752 | 187400000 |
| Wednesday, January 1, 2020 | 16496715 | 177700000 |
| Friday, January 1, 2021 | 16936000 | 122000000 |
| Saturday, January 1, 2022 | 19789000 | 123100000 |
| Sunday, January 1, 2023 | 93150000 | 122500000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Perrigo Company plc and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Perrigo consistently allocated a significant portion of its budget to R&D, peaking in 2018 with a 43% increase from 2014. However, a notable decline of 44% was observed by 2021, reflecting strategic shifts or market challenges.
Conversely, Catalyst Pharmaceuticals showcased a remarkable surge in R&D spending, culminating in a staggering 820% increase by 2023 compared to 2014. This aggressive investment underscores Catalyst's commitment to innovation and growth. The data reveals a compelling narrative of two companies navigating the complexities of pharmaceutical advancements, each with unique approaches to fostering innovation.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Perrigo Company plc
Comparing Innovation Spending: GSK plc and Perrigo Company plc
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Perrigo Company plc
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Perrigo Company plc
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Catalyst Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. or Perrigo Company plc: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Perrigo Company plc vs Celldex Therapeutics, Inc.
Veracyte, Inc. or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Catalyst Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.